QNCX
Quince Therapeutics, Inc.
29.20$
-4.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -23,202.8% | – | – | -4,495.2% | – | – | – | – | – | – | – | |
| – | – | 111.1% | – | – | 9.5% | – | – | – | – | – | – | – | |
| – | – | 3,538.9% | – | – | 669.6% | – | – | – | – | – | – | – | |
| – | – | -2,236.1% | – | – | 1,128.0% | – | – | – | – | – | – | – | |
| – | – | 108.3% | – | – | 79.2% | – | – | – | – | – | – | – | |
| – | – | 24,761.1% | – | – | 6,468.5% | – | – | – | – | – | – | – | |
| – | – | 177,033.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | 527.8% | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | 2,947.2% | – | – | 2,105.4% | – | – | – | – | – | – | – | |
| – | – | -23,311.1% | – | – | -4,574.4% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.